Gallic acid protects against isoproterenol-induced cardiotoxicity in rats.

Abstract

Gallic acid (GA) is a polyphenolic agent with interesting pharmacological impacts on the cardiovascular system. The present study purposed to study the protective effects of GA at 25 and 50mg/kg against isoproterenol (ISO)-induced cardiac damage in ischemia/reperfusion (I/R) in rats. Male Wistar rats were randomly assigned into six groups: Control, Control treated with GA at 25mg/kg (GA25), Control treated with GA at 50mg/kg (GA50), Hypertrophic rats induced by ISO (ISO), Hypertrophic rats treated with GA at 25mg/kg (ISO+GA25), and Hypertrophic rats treated with GA at 50mg/kg (ISO+GA50). Heart isolation was performed to induce a cardiac I/R injury model. Cardiac hemodynamic parameters were recorded. Serum Lactate Dehydrogenase (LDH) and Creatine Kinase-MB (CK-MB) and cardiac Superoxide dismutases (SOD) levels were evaluated. The gene expression of Sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) was assessed. We found that GA at 50mg/kg was significantly increased cardiac function at post I/R period in ISO-induced hypertrophic hearts. Moreover, it suppressed cardiac hypertrophy, the serum LDH and CK-MB levels in ISO injected rats. Administration of GA at 50mg/kg was significantly increased SOD level and SERCA2a gene expression in the hypertrophic hearts. GA at 50mg/kg could improve cardiac performance possibly by increasing antioxidant defense enzymes, reducing cell damage, and enhancing SERCA2a gene expression in hypertrophic heart induced by ISO in I/R injury conditions.